Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
WST Stock Chart & Stats
$266.07
$0.15(0.05%)
At close: 4:00 PM EST
$266.07
$0.15(0.05%)
Day’s Range― - ―
52-Week Range$187.43 - $348.90
Previous CloseN/A
Volume102.64K
Average Volume (3M)664.83K
Market Cap
$20.16B
Enterprise Value$18.72B
Total Cash (Recent Filing)$628.50M
Total Debt (Recent Filing)$303.00M
Price to Earnings (P/E)41.5
Beta0.78
Next Earnings
Feb 12, 2026EPS Estimate
1.83Last Dividend Ex-Date
Nov 12, 2025Dividend Yield0.32%
Share Statistics
EPS (TTM)1.96
Shares Outstanding71,943,410
10 Day Avg. Volume559,910
30 Day Avg. Volume664,828
Financial Highlights & Ratios
PEG Ratio-3.13
Price to Book (P/B)8.91
Price to Sales (P/S)8.27
P/FCF Ratio86.51
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue6.20
Enterprise Value/Gross Profit17.43
Enterprise Value/Ebitda24.25
Forecast
1Y Price Target
$343.10Price Target Upside28.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)7.1
Revenue Forecast (FY)$3.06B
Bulls Say, Bears Say
Bulls Say
Future Growth CatalystsAdditional growth catalysts such as EU Annex-1 regulatory upgrades, expanding biologics pipelines, and highly automated manufacturing support scalability and de-risk execution.
Product TransitionThe transition from standard products to high-value products is contributing to financial leverage and improved performance.
Revenue GrowthWest Pharmaceutical Services reported revenue of $804.6 million, surpassing both the internal estimate of $789.3 million and the consensus estimate of $785.7 million.
Bears Say
Valuation ConcernsDespite a cleaner operating environment and potential upside to numbers, current premium valuation suggests much of this is already baked in.
West Pharmaceutical Services News
WST FAQ
What was West Pharmaceutical Services, Inc.’s price range in the past 12 months?
West Pharmaceutical Services, Inc. lowest stock price was $187.43 and its highest was $348.90 in the past 12 months.
What is West Pharmaceutical Services, Inc.’s market cap?
West Pharmaceutical Services, Inc.’s market cap is $20.16B.
When is West Pharmaceutical Services, Inc.’s upcoming earnings report date?
West Pharmaceutical Services, Inc.’s upcoming earnings report date is Feb 12, 2026 which is in 63 days.
How were West Pharmaceutical Services, Inc.’s earnings last quarter?
West Pharmaceutical Services, Inc. released its earnings results on Oct 23, 2025. The company reported $1.96 earnings per share for the quarter, beating the consensus estimate of $1.685 by $0.275.
Is West Pharmaceutical Services, Inc. overvalued?
According to Wall Street analysts West Pharmaceutical Services, Inc.’s price is currently Undervalued.
Does West Pharmaceutical Services, Inc. pay dividends?
West Pharmaceutical Services, Inc. pays a Quarterly dividend of $0.22 which represents an annual dividend yield of 0.32%. See more information on West Pharmaceutical Services, Inc. dividends here
What is West Pharmaceutical Services, Inc.’s EPS estimate?
West Pharmaceutical Services, Inc.’s EPS estimate is 1.83.
How many shares outstanding does West Pharmaceutical Services, Inc. have?
West Pharmaceutical Services, Inc. has 71,943,410 shares outstanding.
What happened to West Pharmaceutical Services, Inc.’s price movement after its last earnings report?
West Pharmaceutical Services, Inc. reported an EPS of $1.96 in its last earnings report, beating expectations of $1.685. Following the earnings report the stock price went up 10.922%.
Which hedge fund is a major shareholder of West Pharmaceutical Services, Inc.?
Currently, no hedge funds are holding shares in WST
West Pharmaceutical Services Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$343.10 (28.95% Upside)
$343.10 (28.95% Upside)
Blogger Sentiment
Bullish
WST Sentiment 83%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 586.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.1%
Last 30 Days ▲ 5.3%
Last 30 Days ▲ 5.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-16.29%
12-Months-Change
Fundamentals
Return on Equity
16.94%
Trailing 12-Months
Asset Growth
11.72%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) is a global leader in the design and manufacturing of innovative solutions for injectable drug delivery. Operating primarily in the healthcare sector, the company specializes in providing a wide range of products, including component systems for drug delivery, such as rubber stoppers, seals, and prefillable syringes, as well as contract manufacturing services. West serves pharmaceutical and biotechnology companies, helping them ensure the safety and efficacy of their injectable medications through high-quality packaging and delivery systems.
WST Company Deck
WST Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong financial performance with significant growth in key segments and increased guidance for 2025. GLP-1 and Annex 1 projects are driving growth, and the Contract Manufacturing segment is performing well. However, there are challenges in the HVP Delivery Device segment, and the conclusion of the CGM contract poses a future revenue headwind. Overall, the positive aspects slightly outweigh the negatives, indicating a cautiously optimistic outlook.View all WST earnings summariesWST Revenue Breakdown
80.69% Proprietary Products
19.31% Contract-Manufactured Products
0.00% Intersegment sales elimination
WST Stock 12 Month Forecast
Average Price Target
$343.10
▲(28.95% Upside)
Technical Analysis
Ownership Overview
0.57% Insiders
25.37% Mutual Funds
18.88% Other Institutional Investors
25.86% Public Companies and
Individual Investors